Literature DB >> 19865100

Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.

Christine Bodemer1, Olivier Hermine, Fabienne Palmérini, Ying Yang, Catherine Grandpeix-Guyodo, Phillip S Leventhal, Smail Hadj-Rabia, Laurent Nasca, Sophie Georgin-Lavialle, Annick Cohen-Akenine, Jean-Marie Launay, Stéphane Barete, Frédéric Feger, Michel Arock, Benoît Catteau, Beatrix Sans, Jean François Stalder, Francois Skowron, Luc Thomas, Gérard Lorette, Patrice Plantin, Pierre Bordigoni, Olivier Lortholary, Yves de Prost, Alain Moussy, Hagay Sobol, Patrice Dubreuil.   

Abstract

Adult mastocytosis is an incurable clonal disease associated with c-KIT mutations, mostly in exon 17 (D816V). In contrast, pediatric mastocytosis often spontaneously regresses and is considered a reactive disease. Previous studies on childhood mastocytosis assessed only a few patients and focused primarily on codon 816 mutations, with various results. In this study, we analyzed the entire c-KIT sequence from cutaneous biopsies of 50 children with mastocytosis (ages 0-16 years). A mutation of codon 816 (exon 17) was found in 42% of cases, and mutations outside exon 17 were observed in 44%. Unexpectedly, half of the mutations were located in the fifth Ig loop of c-KIT's extracellular domain, which is encoded by exons 8 and 9. All mutations identified in this study were somatic and caused a constitutive activation of c-KIT. There was no clear phenotype-genotype correlation, no clear relationship between the mutations and familial versus spontaneous disease, and no significant change in the relative expression of the c-KIT GNNK+ and GNNK isoforms. These findings strongly support the idea that, although pediatric mastocytosis can spontaneously regress, it is a clonal disease most commonly associated with activating mutations in c-KIT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19865100     DOI: 10.1038/jid.2009.281

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  83 in total

1.  Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.

Authors:  Peter Valent; Cem Akin; Michel Arock; Knut Brockow; Joseph H Butterfield; Melody C Carter; Mariana Castells; Luis Escribano; Karin Hartmann; Philip Lieberman; Boguslaw Nedoszytko; Alberto Orfao; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Rudolf Valenta; Hans-Peter Horny; Dean D Metcalfe
Journal:  Int Arch Allergy Immunol       Date:  2011-10-27       Impact factor: 2.749

Review 2.  [Systemic mastocytosis--definition of an internal disease].

Authors:  Jürgen Homann; Ulrich W Kolck; Andreas Ehnes; Thomas Frieling; Martin Raithel; Gerhard J Molderings
Journal:  Med Klin (Munich)       Date:  2010-09-08

3.  Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis.

Authors:  Melody C Carter; Sarah T Clayton; Hirsh D Komarow; Erica H Brittain; Linda M Scott; Daly Cantave; Donna M Gaskins; Irina Maric; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2015-06-01       Impact factor: 10.793

4.  Kit transduced signals counteract erythroid maturation by MAPK-dependent modulation of erythropoietin signaling and apoptosis induction in mouse fetal liver.

Authors:  N Haas; T Riedt; Z Labbaf; K Baßler; D Gergis; H Fröhlich; I Gütgemann; V Janzen; H Schorle
Journal:  Cell Death Differ       Date:  2014-10-17       Impact factor: 15.828

5.  Gastrointestinal stromal tumors with exon 8 c-kit gene mutation might occur at extragastric sites and have metastasis-prone nature.

Authors:  Takashi Ito; Masahiro Yamamura; Toshihiro Hirai; Takashi Ishikawa; Tatsuo Kanda; Takuya Nakai; Mizuka Ohkouchi; Yuka Hashikura; Koji Isozaki; Seiichi Hirota
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 6.  Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases.

Authors:  Kenneth Verstraete; Savvas N Savvides
Journal:  Nat Rev Cancer       Date:  2012-10-18       Impact factor: 60.716

Review 7.  Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics.

Authors:  Britta Haenisch; Markus M Nöthen; Gerhard J Molderings
Journal:  Immunology       Date:  2012-11       Impact factor: 7.397

8.  Evidence for contribution of epigenetic mechanisms in the pathogenesis of systemic mast cell activation disease.

Authors:  Britta Haenisch; Holger Fröhlich; Stefan Herms; Gerhard J Molderings
Journal:  Immunogenetics       Date:  2014-03-14       Impact factor: 2.846

9.  Structure, domain organization, and different conformational states of stem cell factor-induced intact KIT dimers.

Authors:  Yarden Opatowsky; Irit Lax; Francisco Tomé; Franziska Bleichert; Vinzenz M Unger; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-21       Impact factor: 11.205

Review 10.  Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome.

Authors:  Peter Valent; Cem Akin; Patrizia Bonadonna; Karin Hartmann; Knut Brockow; Marek Niedoszytko; Boguslaw Nedoszytko; Frank Siebenhaar; Wolfgang R Sperr; Joanna N G Oude Elberink; Joseph H Butterfield; Ivan Alvarez-Twose; Karl Sotlar; Andreas Reiter; Hanneke C Kluin-Nelemans; Olivier Hermine; Jason Gotlib; Sigurd Broesby-Olsen; Alberto Orfao; Hans-Peter Horny; Massimo Triggiani; Michel Arock; Lawrence B Schwartz; Dean D Metcalfe
Journal:  J Allergy Clin Immunol Pract       Date:  2019-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.